Insider Transactions in Q2 2023 at Steris PLC (STE)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 02
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
498
-1.61%
|
$102,090
$205.47 P/Share
|
|
Jun 02
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
247
-2.75%
|
$50,635
$205.47 P/Share
|
|
Jun 02
2023
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,422
-4.89%
|
$496,510
$205.47 P/Share
|
|
Jun 02
2023
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
127
-1.84%
|
$26,035
$205.47 P/Share
|
|
Jun 02
2023
|
Andrew Xilas SVP and GM, Dental |
SELL
Payment of exercise price or tax liability
|
Direct |
103
-1.72%
|
$21,115
$205.47 P/Share
|
|
Jun 01
2023
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,491
-2.92%
|
$301,182
$202.42 P/Share
|
|
Jun 01
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
43
-0.48%
|
$8,686
$202.42 P/Share
|
|
Jun 01
2023
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
60
-0.86%
|
$12,120
$202.42 P/Share
|
|
Jun 01
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
225
-0.72%
|
$45,450
$202.42 P/Share
|
|
Jun 01
2023
|
Mary Clare Fraser SVP & Chief HRO |
SELL
Payment of exercise price or tax liability
|
Direct |
236
-2.47%
|
$47,672
$202.42 P/Share
|
|
May 31
2023
|
Michael J Tokich Sr. Vice Pres., CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,879
+8.37%
|
-
|
|
May 31
2023
|
Michael J Tokich Sr. Vice Pres., CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
830
-2.11%
|
$165,170
$199.97 P/Share
|
|
May 31
2023
|
Cary L Majors SVP and President, Healthcare |
BUY
Grant, award, or other acquisition
|
Direct |
2,697
+16.76%
|
-
|
|
May 31
2023
|
Cary L Majors SVP and President, Healthcare |
SELL
Payment of exercise price or tax liability
|
Direct |
649
-5.72%
|
$129,151
$199.97 P/Share
|
|
May 31
2023
|
Daniel A Carestio President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
12,924
+20.21%
|
-
|
|
May 31
2023
|
Daniel A Carestio President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,506
-3.8%
|
$299,694
$199.97 P/Share
|
|
May 31
2023
|
Renato Tamaro V.P. & Corporate Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
723
+9.77%
|
-
|
|
May 31
2023
|
Renato Tamaro V.P. & Corporate Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
175
-2.86%
|
$34,825
$199.97 P/Share
|
|
May 31
2023
|
Andrew Xilas SVP and GM, Dental |
BUY
Grant, award, or other acquisition
|
Direct |
1,278
+17.57%
|
-
|
|
May 31
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
BUY
Grant, award, or other acquisition
|
Direct |
1,734
+16.14%
|
-
|
|
May 31
2023
|
Julia Madsen Sr. VP and GM, Life Sciences |
SELL
Payment of exercise price or tax liability
|
Direct |
32
-0.44%
|
$6,368
$199.97 P/Share
|
|
May 31
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
3,471
+10.05%
|
-
|
|
May 31
2023
|
John Adam Zangerle Sr. VP, Gen Counsel, and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
249
-0.89%
|
$49,551
$199.97 P/Share
|
|
May 31
2023
|
Mary Clare Fraser SVP & Chief HRO |
BUY
Grant, award, or other acquisition
|
Direct |
2,313
+19.47%
|
-
|
|
May 31
2023
|
Karen L Burton VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
1,020
+12.76%
|
-
|
|
May 31
2023
|
Karen L Burton VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
76
-1.26%
|
$15,124
$199.97 P/Share
|
|
May 16
2023
|
Cynthia L Feldmann Director |
SELL
Open market or private sale
|
Direct |
2,058
-48.85%
|
$430,122
$209.11 P/Share
|
|
May 16
2023
|
Cynthia L Feldmann Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,058
+42.69%
|
$176,988
$86.23 P/Share
|
|
May 16
2023
|
Richard C Breeden Director |
SELL
Open market or private sale
|
Direct |
12,130
-30.25%
|
$2,523,040
$208.61 P/Share
|
|
May 15
2023
|
Richard C Breeden Director |
SELL
Open market or private sale
|
Direct |
2,737
-6.39%
|
$577,507
$211.0 P/Share
|
|
May 15
2023
|
Jacqueline B Kosecoff Director |
SELL
Open market or private sale
|
Direct |
4,657
-100.0%
|
$987,284
$212.56 P/Share
|
|
May 15
2023
|
Jacqueline B Kosecoff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,657
+50.0%
|
$200,251
$43.92 P/Share
|
|
May 15
2023
|
Mohsen Sohi Director |
SELL
Open market or private sale
|
Direct |
2,069
-8.47%
|
$438,628
$212.28 P/Share
|
|
May 15
2023
|
Mohsen Sohi Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,069
+7.81%
|
$88,967
$43.92 P/Share
|